ArticleScandinavian journal of immunology2026
Impact of CD38 Deficiency on B Cell Development in CD19-Deficient Mice.
Article in Scandinavian journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Physical interaction between the CD38 and CD19 proteins has been previously described. However, this association through the development of B lymphocytes has yet to be thoroughly investigated. To address this, we generated mice with a simultaneous absence of CD38 and CD19 proteins. Our results showed that Cd38 -/- Cd19 -/- mice had reduced survival. We suggest that the combined loss of CD38 and CD19 proteins results in normal B-cell maturation in the BM compared to WT mice. Nonetheless, these observations differ from those observed in Cd19 -/- mice. In DKO mice, a change in the proportion of the mature B-cell subset in BM was found in contrast to Cd38 -/- mice. On the periphery, reduced numbers of total splenocytes and total B cells were observed in DKO mice. In addition, some defects in splenic B-cell development were observed. For example, fewer absolute numbers of T1, T2, and mature B cells were found in comparison with WT mice. However, these subsets have no significant difference compared to Cd19 -/- mice. The MZ B-cell subset was almost depleted in Cd38-/-Cd19-/- mice, and a contrary effect was observed in FO B cells. Although not many differences were found in the proportions and absolute numbers during the different maturation stages of B cells between DKO and Cd19 -/- mice, a downward trend was observed in some of the steps during B-cell ontogeny. For this reason, the activation, proliferation, and immunoglobulin secretion, as well as the GC formation and MZ microenvironment in response to different stimuli, must be explored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.